| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary MultiTAA-specific T cell technology. This method involves producing T cells that are not genetically modified but are specifically designed to target tumors. These specialized T cells can identify multiple antigens associated with tumors, allowing them to effectively eliminate cancer cells that express these markers. Marker Therapeutics' MultiTAA-specific T cell therapies encompass patient-derived (autologous) T cells for treating lymphoma and various solid tumors, as well as donor-derived (allogeneic) T cells for acute myeloid leukemia and acute lymphoblastic leukemia. They also provide "off-the-shelf" solutions applicable to a range of diseases. In addition to T cell therapies, the company is advancing peptide-based immunotherapeutic vaccines. This pipeline includes TPIV100/110, developed to combat breast and ovarian cancer cells, and TPIV200, which is currently undergoing Phase 2 clinical trials for the treatment of breast and ovarian cancers. Founded in 1999, Marker Therapeutics maintains its headquarters in Houston, Texas.
Over the last 12 months, insiders at Marker Therapeutics, Inc. have bought $0 and sold $0 worth of Marker Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Marker Therapeutics, Inc. have bought $1.81M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 554,250 shares for transaction amount of $1.77M was made by New Enterprise Associates 16, L.P. (10 percent owner) on 2024‑12‑23.
| 2024-12-23 | New Enterprise Associates 16, L.P. | 10 percent owner | 554,250 5.7713% | $3.20 | $1.77M | -63.30% | ||
| 2024-12-23 | ELMS STEVE | director | 11,085 0.1154% | $3.20 | $35,472 | -63.30% | ||
| 2021-05-18 | Wasserman Frederick Gerald | director | 10,000 0.0119% | $2.41 | $24,098 | -43.03% | ||
| 2021-03-16 | Walker Paul Edward | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Sonsini Peter W. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | SANDELL SCOTT D | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | New Enterprise Associates 16, L.P. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | MAKOWER JOSHUA | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Makhzoumi Mohamad | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Florence Anthony A. Jr. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Chang Carmen | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Behbahani Ali | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | BASKETT FOREST | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
| 2021-03-16 | Wilson John Robert | director | 1.71M 2.8562% | $1.75 | $3M | -4.30% | ||
| 2021-03-16 | ELMS STEVE | director | 1.14M 1.9041% | $1.75 | $2M | -4.30% | ||
| 2021-03-16 | Vera Juan | Chief Development Officer | 571,428 0.9521% | $1.75 | $999,999 | -4.30% | ||
| 2021-03-16 | Hoang Peter L. | President and CEO | 142,857 0.238% | $1.75 | $250,000 | -4.30% | ||
| 2021-03-16 | Eansor Norman David | director | 14,285 0.238% | $17.50 | $249,988 | -4.30% | ||
| 2019-08-14 | Hoang Peter L. | President and CEO | 10,000 0.0219% | $4.62 | $46,200 | -41.13% | ||
| 2018-05-14 | Eastern Capital LTD | 10 percent owner | 2.6M 17.57% | $2.40 | $6.24M | +127.00% |
| MAKOWER JOSHUA | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| SANDELL SCOTT D | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| BASKETT FOREST | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Walker Paul Edward | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Sonsini Peter W. | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Florence Anthony A. Jr. | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Behbahani Ali | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Makhzoumi Mohamad | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Chang Carmen | 10 percent owner | 10714285 64.2609% | $12.64M | 1 | 0 | <0.0001% |
| Wilson John Robert | director | 7799350 46.778% | $9.2M | 1 | 0 | <0.0001% |
| Eastern Capital LTD | 10 percent owner | 5300002 31.7877% | $6.25M | 1 | 0 | +127% |
| Vera Juan | Chief Development Officer | 2564487 15.381% | $3.03M | 1 | 0 | <0.0001% |
| New Enterprise Associates 16, L.P. | 10 percent owner | 1625678 9.7503% | $1.92M | 2 | 0 | <0.0001% |
| Hoang Peter L. | President and CEO | 332568 1.9946% | $392,430.24 | 2 | 0 | <0.0001% |
| ELMS STEVE | director | 325370 1.9515% | $383,936.60 | 2 | 0 | <0.0001% |
| CORIN DENIS | President and CFO | 135300 0.8115% | $159,654.00 | 0 | 1 | |
| Wasserman Frederick Gerald | director | 52565 0.3153% | $62,026.70 | 1 | 0 | <0.0001% |
| Eansor Norman David | director | 16713 0.1002% | $19,721.34 | 1 | 0 | <0.0001% |
$1,993,425 | 46 | -21.90% | $16.08M | |
$95,344,010 | 36 | -18.97% | $14.94M | |
$30,257,839 | 29 | -15.72% | $23.91M | |
$555,628 | 21 | 43.52% | $20.2M | |
Marker Therapeutics, Inc. (MRKR) | $114,619,342 | 20 | -7.41% | $19.67M |
$742,412 | 14 | -50.36% | $19.38M | |
$365,792 | 12 | -15.77% | $18.94M | |
$1,246,170 | 12 | 65.67% | $20.72M | |
$4,146,041 | 11 | -40.86% | $16.68M | |
$176,752 | 10 | -28.86% | $23.38M | |
$4,176,565 | 9 | 18.77% | $22.6M | |
$8,971,546 | 8 | 6.18% | $19.9M | |
$654,995 | 7 | -60.00% | $20.68M | |
$5,117,729 | 6 | -52.29% | $16.46M | |
$2,060,158 | 5 | -21.35% | $15.58M | |
$1,124,966 | 4 | 0.87% | $18.96M | |
$150,000 | 1 | 5.48% | $24.31M | |
$35,811 | 1 | -10.94% | $23.7M | |
$30,190 | 1 | -42.39% | $15.03M |
| Increased Positions | 19 | +59.38% | 728,901 | +20.88% |
| Decreased Positions | 9 | -28.13% | 175,237 | -5.02% |
| New Positions | 9 | New | 312,083 | New |
| Sold Out Positions | 6 | Sold Out | 163,521 | Sold Out |
| Total Postitions | 42 | +31.25% | 4M | +15.86% |
| Nea Management Company, Llc | $2,504.00 | 9.56% | 1.63M | 0 | 0% | 2025-09-30 |
| Blue Owl Capital Holdings Lp | $854.00 | 3.26% | 554,250 | 0 | 0% | 2025-09-30 |
| Aisling Capital Management Lp | $501.00 | 1.91% | 325,370 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $462.00 | 1.76% | 299,781 | +24,436 | +8.88% | 2025-09-30 |
| Renaissance Technologies Llc | $164.00 | 0.63% | 106,250 | +36,808 | +53.01% | 2025-09-30 |
| Geode Capital Management, Llc | $148.00 | 0.57% | 96,316 | +548 | +0.57% | 2025-09-30 |
| Osaic Holdings, Inc. | $125.00 | 0.48% | 81,081 | +61,504 | +314.17% | 2025-09-30 |
| Lpl Financial Llc | $90.00 | 0.35% | 58,747 | -15,000 | -20.34% | 2025-09-30 |
| Torrey Growth & Income Advisors | $80.00 | 0.31% | 51,984 | +51,984 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $73.00 | 0.28% | 47,603 | +47,603 | New | 2025-09-30 |